Humana stock hits new 52-week low amid mixed analyst ratings and lowered price targets.

Humana Inc. reached a new 52-week low at $163.11 during recent trading, reflecting investor concerns despite the company beating earnings estimates for its latest quarter. Several analysts have downgraded their price targets, with the consensus rating at "Hold" and an average target price of $225.48. The company reported a slight profit beat and revenue growth but faces pressure from lowered forecasts and market sentiment. Humana also announced a quarterly dividend and saw insider buying, indicating some confidence in the stock's future prospects.